REQUEST A DEMO
Total
USD $0.00
Search more companies

Rudraksh Pharma And Surgico Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rudraksh Pharma And Surgico Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Rudraksh Pharma And Surgico Private Limited is an unlisted company, incorporated on 06/04/1995. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ1995PTC025387 and registration number is 025387. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
176/6, G.I.D.C. Phase-I, Naroda
Ahmedabad; Gujarat; Postal Code: 382330

Contact Details: Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Outstanding Shares:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Registered Capital:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Incorporation Date:
April 06, 1995
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Rudraksh Pharma And Surgico Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.34%
Total operating revenue
-8.5%
Operating profit (EBIT)
-26.16%
EBITDA
-25.33%
Net Profit (Loss) for the Period
-25.76%
Total assets
-50.38%
Total equity
12.1%
Operating Profit Margin (ROS)
-1%
Net Profit Margin
-0.72%
Return on Equity (ROE)
-5.5%
Debt to Equity Ratio
-31.63%
Quick Ratio
1.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?